Bionime Corporation (4737.TW)

TWD 66.0

(-0.9%)

Market Cap (In TWD)

4.02 Billion

Revenue (In TWD)

1.75 Billion

Net Income (In TWD)

6.2 Million

Avg. Volume

46.31 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
60.8-76.6
PE
-
EPS
-
Beta Value
0.602
ISIN
TW0004737002
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Chun-Mu Huang
Employee Count
-
Website
https://www.bionime.com
Ipo Date
2010-12-23
Details
Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Algeria, Egypt, and internationally. The company offers blood glucose monitors, as well as accessories, such as test strips and lancing devices medical equipment companies, pharmacies, and hospitals. It is also involved in the provision of biotechnology services; examining of pharmaceuticals; and selling of precision instruments. The company was incorporated in 2003 and is based in Taichung, Taiwan.